Bibliography
- Goldman LM, Genel M, Bezman RJ, et al. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 1998;279:1100-7
- American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46:894-921
- American Association of Pediatrics. Clinical practice guidelines: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000;105:1158-70
- Mannuzza S, Klein RG. Long-term prognosis in attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000;9:711-26
- Pliszka S. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder in children and adolescents. J Clin Psychiatry 1998;59(Suppl 7):50-8
- Spencer T, Biederman J, Wilens T, et al. Pharmacotherapy of attention-deficit/hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996;35(4):409-32
- Greenhill LL, Pliszka S, Dulcan MK, et al. Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2001;40:1352-5
- Daytrana [Package Insert]. Wayne, PA: Shire US Inc; 01/08
- Heal DJ. DM Methylphenidate and its Isomers: Their Role in the Treatment of Attention-Deficit Hyperactivity Disorder Using a Transdermal Delivery System. CNS Drugs 2006;20(9):713-38
- Pelham WE, Burrows-Maclean L, Gnagy EM, et al. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Exp Clin Psychopharmacol 2005;13:111-26
- Pelham WE, Manos MJ, Ezzell CE, et al. A dose-ranging study of a methylphenidate transdermal system in children with ADHD. J Am Acad Child Adolesc Psychiatry 2005;44:522-9
- McGough JJ, Wigal SB, Abikoff H, et al. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD. J Atten Disord 2006;9:476-85
- Findling RL, Bukstein OG, Melmed RD, et al. A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2008;69:149-59
- Findling RL, Wigal SB, Bukstein OG, et al. A 12-month open label trial of the safety and effectiveness of transdermal methylphenidate for pediatric ADHD (SUBMITTED)
- Wilens TE, Boellner SW, Lopez FA, et al. Vayring the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder. J Am Acad Chad Adolesc Psychiatry 2008;47:700-7
- Faraone SV, Glatt SJ, Bukstein OG, et al. Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD. J Atten Disord 2009;12(4):308-15
- Lopez FA, Findling RL, Burnside J, Madhoo M. Effects of Methylphenidate Transdermal System (MTS) on growth in children with ADHD presented at the U.S. Psychiatric & Mental Health Congress, San Diego, CA October 30, 2008
- http://www.quote.com/news/story.action;jsessionid=abcGB6pZbPr8o6Zg3ip_r?id=EUR050x3549&pg=10 [Accessed 26 Feb 2009]
- Arnold LE, Lindsay RL, Lopez FA, et al. Treating attention-deficit/hyperactivity disorder with a stimulant transdermal patch: the clinical art. Ramadan Y. Available from: www.pediatrics.org/cgi/doi/10.1542/peds.2007-0542